SEARCH

SEARCH BY CITATION

References

  • 1
    Petro, J. B., Gerstein, R. M., Lowe, J., Carter, R. S., Shinners, N. and Khan, W. N., Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 2002. 277: 4800948019.
  • 2
    Carman, J. A., Wechsler-Reya, R. J. and Monroe, J. G., Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling. J. Immunol. 1996. 156: 45624569.
  • 3
    Su, T. T. and Rawlings, D. J., Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B-cell development. J. Immunol. 2002. 168: 21012110.
  • 4
    Meyer-Bahlburg, A., Andrews, S. F., Yu, K. O., Porcelli, S. A. and Rawlings, D. J., Characterization of a late transitional B-cell population highly sensitive to BAFF-mediated homeostatic proliferation. J. Exp. Med. 2008. 205: 155168.
  • 5
    Andrews, S. F. and Rawlings, D. J., Transitional B cells exhibit a B-cell receptor-specific nuclear defect in gene transcription. J. Immunol. 2009. 182: 28682878.
  • 6
    Meyer-Bahlburg, A., Bandaranayake, A. D., Andrews, S. F. and Rawlings, D. J., Reduced c-myc expression levels limit follicular mature B-cell cycling in response to TLR signals. J. Immunol. 2009. 182: 40654075.
  • 7
    Scharenberg, A. M., Humphries, L. A. and Rawlings, D. J., Calcium signalling and cell-fate choice in B cells. Nat. Rev. Immunol. 2007. 7: 778789.
  • 8
    Winslow, M. M., Gallo, E. M., Neilson, J. R. and Crabtree, G. R., The calcineurin phosphatase complex modulates immunogenic B-cell responses. Immunity 2006. 24: 141152.
  • 9
    McKinsey, T. A., Zhang, C. L. and Olson, E. N., MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 2002. 27: 4047.
  • 10
    Youn, H. D. and Liu, J. O., Cabin1 represses MEF2-dependent Nur77 expression and T-cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 2000. 13: 8594.
  • 11
    Khiem, D., Cyster, J. G., Schwarz, J. J. and Black, B. L., A p38 MAPK-MEF2C pathway regulates B-cell proliferation. Proc. Natl. Acad. Sci. USA 2008. 105: 1706717072.
  • 12
    Wilker, P. R., Kohyama, M., Sandau, M. M., Albring, J. C., Nakagawa, O., Schwarz, J. J. and Murphy, K. M., Transcription factor Mef2c is required for B-cell proliferation and survival after antigen receptor stimulation. Nat. Immunol. 2008. 9: 603612.
  • 13
    Swanson, B. J., Jack, H. M. and Lyons, G. E., Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. Mol. Immunol. 1998. 35: 445458.
  • 14
    Youn, H. D., Chatila, T. A. and Liu, J. O., Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 2000. 19: 43234331.
  • 15
    Sather, B. D., Ryu, B. Y., Stirling, B. V., Garibov, M., Kerns, H. M., Humblet-Baron, S., Astrakhan, A. et al., Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B-cell disorders. Mol. Ther. 2011. 19: 515--525.
  • 16
    Allman, D., Lindsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A. and Hardy, R. R., Resolution of three nonproliferative immature splenic B-cell subsets reveals multiple selection points during peripheral B-cell maturation. J. Immunol. 2001. 167: 68346840.
  • 17
    Chung, J. B., Sater, R. A., Fields, M. L., Erikson, J. and Monroe, J. G., CD23 defines two distinct subsets of immature B cells which differ in their responses to T-cell help signals. Int. Immunol. 2002. 14: 157166.
  • 18
    Enders, A., Bouillet, P., Puthalakath, H., Xu, Y., Tarlinton, D. M. and Strasser, A., Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 2003. 198: 11191126.
  • 19
    Kovesdi, D., Paszty, K., Enyedi, A., Kiss, E., Matko, J., Ludanyi, K., Rajnavolgyi, E. et al., Antigen receptor-mediated signaling pathways in transitional immature B cells. Cell Signal 2004. 16: 881889.
  • 20
    Chung, J. B., Silverman, M. and Monroe, J. G., Transitional B cells: step by step towards immune competence. Trends Immunol. 2003. 24: 343349.
  • 21
    Brezski, R. J. and Monroe, J. G., B-cell antigen receptor-induced Rac1 activation and Rac1-dependent spreading are impaired in transitional immature B cells due to levels of membrane cholesterol. J. Immunol. 2007. 179: 44644472.
  • 22
    Hoek, K. L., Antony, P., Lowe, J., Shinners, N., Sarmah, B., Wente, S. R., Wang, D. et al., Transitional B-cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B-cell receptor engagement. J. Immunol. 2006. 177: 54055413.
  • 23
    Castro, I., Wright, J. A., Damdinsuren, B., Hoek, K. L., Carlesso, G., Shinners, N. P., Gerstein, R. M. et al., B-cell receptor-mediated sustained c-Rel activation facilitates late transitional B-cell survival through control of B-cell activating factor receptor and NF-kappaB2. J. Immunol. 2009. 182: 77297737.
  • 24
    Benschop, R. J., Melamed, D., Nemazee, D. and Cambier, J. C., Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J. Exp. Med. 1999. 190: 749756.
  • 25
    Benschop, R. J., Brandl, E., Chan, A. C. and Cambier, J. C., Unique signaling properties of B-cell antigen receptor in mature and immature B cells: implications for tolerance and activation. J. Immunol. 2001. 167: 41724179.
  • 26
    Samanta, D. N., Palmetshofer, A., Marinkovic, D., Wirth, T., Serfling, E. and Nitschke, L., B-cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice. J. Immunol. 2005. 174: 47974802.
  • 27
    Liu, S., Liu, P., Borras, A., Chatila, T. and Speck, S. H., Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 1997. 16: 143153.
  • 28
    Esau, C., Boes, M., Youn, H. D., Tatterson, L., Liu, J. O. and Chen, J., Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells. J. Exp. Med. 2001. 194: 14491459.
  • 29
    Pan, F., Ye, Z., Cheng, L. and Liu, J. O., Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). J. Biol. Chem. 2004. 279: 1447714480.
  • 30
    Kerns, H. M., Ryu, B. Y., Stirling, B. V., Sather, B. D., Astrakhan, A., Humblet-Baron, S., Liggitt, D. et al., B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia. Blood 2010. 115: 21462155.
  • 31
    Ramachandran, B., Yu, G., Li, S., Zhu, B. and Gulick, T., Myocyte enhancer factor 2A is transcriptionally autoregulated. J. Biol. Chem. 2008. 283: 1031810329.